Results 171 to 180 of about 209,966 (285)

The Fibrosis Across Organs Symposium: A Roadmap for Future Research Priorities. [PDF]

, 2019
Barnes, Teresa R., Brenner, David A., Brown, Kevin K., Cosgrove, Gregory P., Crane, Stephen, Doherty, Dennis E., for the Fibrosis Across Organs Symposium Working Group, Hewitson, Timothy D., Jugdutt, Bodh I., Kervitsky, Dolly J., McKinsey, Timothy A., Richeldi, Luca, Roman, Jesse, Schnapp, Lynn M., Tager, Andrew M., Tosi, John D., White, Eric S.   +16 more
core   +2 more sources

Unveiling CCL2 and CXCL1: Key biomarkers and therapeutic targets in idiopathic pulmonary fibrosis. [PDF]

Sarcoidosis Vasc Diffuse Lung Dis
Pan J, Li G, Pu Y, Li P, Zhou Y.
europepmc   +1 more source

Adverse side-effects of antifibrotic drugs and outcome of treatment in idiopathic pulmonary fibrosis. [PDF]

J Thorac Dis
Jovanovic D, Mogulkoc N, Sterclova M, Kramer M, Müller V, Bartos V, Plackova M, Doubkova M, Lewandowska K, Szymanowska-Narloch A, Zurkova M, Ovesna P, Vasakova MK.   +12 more
europepmc   +1 more source

Author response: Autologous P63+ lung progenitor cell transplantation in idiopathic pulmonary fibrosis: a phase 1 clinical trial

Shiyu Zhang, Min Zhou, Chi Shao, Yu Zhao, Mingzhe Liu, Lei Ni, Zhiyao Bao, Qiurui Zhang, Ting Zhang, Qun Luo, Jieming Qu, Zuojun Xu, Wei Zuo   +12 more
openalex   +1 more source

Unveiling the role of circulating periostin in patients with idiopathic pulmonary fibrosis: A prognostic meta-analysis. [PDF]

Sarcoidosis Vasc Diffuse Lung Dis
Alghwyeen W, Mohamed SF, Hashim AS, Tawfik AM, Kertam A.   +4 more
europepmc   +1 more source

Minimum clinically important difference in Quantitative Lung Fibrosis score associated with all-cause mortality in idiopathic pulmonary fibrosis: subanalysis from two phase II trials of pamrevlumab

Grace Hyun J. Kim, Xueping Zhang, Matthew S. Brown, Lona Poole, Jonathan Goldin   +4 more
openalex   +1 more source

Prognostic Value of a Cardiopulmonary Exercise Testing‐Derived Summed Score in Idiopathic Pulmonary Fibrosis and Connective Tissue Disease‐Associated Interstitial Lung Disease: A Prospective Cohort Study [PDF]

Yu‐Lin Tsai, Kai‐Ming Chang, Chung‐Shih Chin, Chiann‐Yi Hsu, Yi‐Hsuan Yu, Y-W Cheng, Pin‐Kuei Fu   +6 more
openalex   +1 more source

Acquired whole-lung mismatched perfusion defects on pulmonary ventilation/perfusion scintigraphy [PDF]

, 2018
Alberg, Holmes, Pickhardt, Raghu, Rossi, Saad, Slonim, Sostman   +7 more
core   +2 more sources

Predictors of Disease Progression in Idiopathic Pulmonary Fibrosis Under Antifibrotic Therapy: A Retrospective Study. [PDF]

Cureus
Kishaba T, Higa M, Nagano H.
europepmc   +1 more source

Idiopathic pulmonary fibrosis: Disease mechanisms and drug development.

Pharmacology and Therapeutics, 2020
P. Spagnolo, J. Kropski, Mark G. Jones, Joyce S. Lee, G. Rossi, T. Karampitsakos, T. Maher, A. Tzouvelekis, C. Ryerson   +8 more
semanticscholar   +1 more source